🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is evaluating Lorlatinib in combination with Crizotinib...
Status
Unknown
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-05-01
Trial ID
NCT04292119
Treatments Being Tested
The purpose of this study is to evaluate the effect of various degrees of h...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-03-06
Trial ID
NCT05490030
Treatments Being Tested
This study will evaluate the safety, tolerability, drug levels, molecular e...
Status
Completed
Location
Local Institution - 002-805
Start Date
2020-04-07
Trial ID
NCT04330664
This study was a Phase Ib, multi-center, open-label study of TNO155 in comb...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2019-07-30
Trial ID
NCT04000529
Treatments Being Tested
To evaluate the safety and tolerability of sotorasib administered in invest...
Status
Active Not Recruiting
Location
Arizona Oncology Associates Professional Corporation
Start Date
2019-12-17
Trial ID
NCT04185883
The purpose of this Phase 1 study is to evaluate the effect of various degr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-03-19
Trial ID
NCT05541159
Treatments Being Tested
The purpose of this first in human (FIH) trial was to characterize the safe...
Status
Terminated
Location
H Lee Moffitt Cancer Center and Research Institute
Start Date
2017-05-26
Trial ID
NCT03114319
Treatments Being Tested
This is a phase Ib/II open label study. The escalation part will characteri...
Status
Active Not Recruiting
Location
Emory University School of Medicine-Winship Cancer Institute
Start Date
2021-02-24
Trial ID
NCT04699188
Treatments Being Tested
A phase Ib, open-label platform study of select drug combinations chosen in...
Status
Terminated
Location
University of California LA Santa Monica Location
Start Date
2020-07-22
Trial ID
NCT04294160
Treatments Being Tested
The purpose of this study is to allow continued access to opnurasib (JDQ443...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-06-08
Trial ID
NCT07468071
Treatments Being Tested